VTV THERAPEUTICS INC- CL A (VTVT)
US9183852048 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.45M | 12.13M | 13.42M | 5.75M | 1.78M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 102.00K | 12.42M | 60.00K | 160.00K | 10.00K | |||
| Other Current Assets | 1.11M | 2.56M | 2.15M | 1.31M | 1.06M | |||
| Total Current Assets | 10.66M | 27.09M | 15.62M | 7.22M | 2.84M | |||
| Non-Current Assets | ||||||||
| PPE Net | 361.00K | 560.00K | 680.00K | 850.00K | 1.00M | |||
| Investments And Advances | 0.00 | 5.59M | 9.17M | 6.73M | 2.48M | |||
| Other Non-Current Assets | N/A | N/A | N/A | 0.00 | 2.94M | |||
| Total Non-Current Assets | 361.00K | 6.15M | 9.85M | 7.57M | 6.43M | |||
| TOTAL ASSETS | 11.02M | 33.24M | 25.47M | 14.79M | 9.27M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 191.00K | 220.00K | 260.00K | 80.00K | 6.17M | |||
| Accrued Expenses | 6.34M | 5.01M | 6.33M | 4.35M | 4.95M | |||
| Accounts Payable | 4.08M | 2.46M | 1.88M | 1.93M | 2.23M | |||
| Other Current Liabilities | 17.00K | 20.00K | 40.00K | 30.00K | 30.00K | |||
| Total Current Liabilities | 10.62M | 7.71M | 8.50M | 6.39M | 13.38M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 18.95M | 19.69M | 1.75M | 4.61M | 4.73M | |||
| Total Non-Current Liabilities | 25.08M | 36.27M | 26.71M | 88.50M | 44.91M | |||
| TOTAL LIABILITIES | 35.70M | 43.98M | 35.21M | 94.89M | 58.29M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -281.04M | -265.52M | -248.83M | -290.04M | -233.52M | |||
| Additional Paid In Capital | 256.33M | 253.74M | 238.19M | 209.16M | 183.86M | |||
| Minority Interest | 11.85M | 22.49M | 29.70M | 88.20M | 49.07M | |||
| Common Shares | 27.00K | 1.05M | 900.00K | 770.00K | 640.00K | |||
| Shares Outstanding | 2.66M | 104.58M | 90.04M | 77.14M | 64.01M | |||
| Tangible Book Value per Share | -9.27 | -0.10 | -0.11 | -1.04 | -0.77 | |||
| Total Shareholders' Equity | -24.68M | -10.74M | -9.74M | -80.10M | -49.02M | |||
| TOTAL LIABILITIES AND EQUITY | 11.02M | 33.24M | 25.47M | 14.79M | 9.27M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.00 | 3.51 | 1.84 | 1.13 | 0.21 | |||
| Return On Assets (ROA) | -183.79% | -57.64% | -51.00% | -57.47% | -193.20% | |||
All data in USD